Brief: Cryofocus Medtech Shanghai Says NMPA Approved Key Components Of Atrial Fibrillation Cryoablation System
05/12/2023 15:04
Dec 5 (Reuters) - Cryofocus Medtech Shanghai Co Ltd
6922.HK :
* ON DEC 4, CHINA'S NMPA APPROVED KEY COMPONENTS OF ATRIAL
FIBRILLATION CRYOABLATION SYSTEM
Source text for Eikon: ID:nHKS7brcX2
Further company coverage: 6922.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cryofocus Medtech (Shanghai) Co
See all newsBrief: Cryofocus Medtech (Shanghai) To Allot & Issue 7.5 Million H Shares
Brief: Cryofocus Medtech (Shanghai) Says Anti-Gastroesophageal Reflux System Granted Approval By Nmpa
Brief: Cryofocus Medtech Shanghai Says China's NMPA Approves Registration Change Of Disposable Cryoprobe Of Cryoadhesion System
Brief: Cryofocus Medtech Shanghai Says US' FDA Grants Breakthrough Device Designation For Asthma Cryoablation System
Brief: Cryofocus Medtech Shanghai Receives NMPA Approval For Malignant Stenosis Cryoablation System